Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-25-018481
Filing Date
2025-10-17
Accepted
2025-10-17 16:37:58
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 279536
2 EX-5.1 ex5-1.htm EX-5.1 18233
3 EX-23.1 ex23-1.htm EX-23.1 1041
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 23393
5 GRAPHIC forms-3_001.jpg GRAPHIC 9348
6 GRAPHIC forms-3_002.jpg GRAPHIC 3376
7 GRAPHIC ex5-1_001.jpg GRAPHIC 9323
8 GRAPHIC ex23-1_001.jpg GRAPHIC 348486
  Complete submission text file 0001493152-25-018481.txt   958159

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5895
Mailing Address 34 SHREWSBURY AVE SUITE 1C RED BANK NJ 07701
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290940 | Film No.: 251401251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)